Evidence map›Paper›PMID 26811604›Full record

SynthesisWorld journal of gastroenterology2016

Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis.

Giovanni Brandi, Stefania De Lorenzo, Margherita Nannini, Stefania Curti, Marta Ottone, Filippo Gustavo Dall'Olio, Maria Aurelia Barbera, Maria Abbondanza Pantaleo, Guido Biasco

Open access · hybridAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 5 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 5 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.International journal of molecular sciences · 2018
    Pooled it
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Giovanni BrandiGiovanni Brandi, Maria Abbondanza Pantaleo, Guido Biasco, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital and "G. Prodi" Interdepartmental Center for Cancer Research, Bologna University, 40138 Bologna, Italy.
Stefania De LorenzoGiovanni Brandi, Maria Abbondanza Pantaleo, Guido Biasco, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital and "G. Prodi" Interdepartmental Center for Cancer Research, Bologna University, 40138 Bologna, Italy.
Margherita NanniniGiovanni Brandi, Maria Abbondanza Pantaleo, Guido Biasco, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital and "G. Prodi" Interdepartmental Center for Cancer Research, Bologna University, 40138 Bologna, Italy.
Stefania CurtiGiovanni Brandi, Maria Abbondanza Pantaleo, Guido Biasco, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital and "G. Prodi" Interdepartmental Center for Cancer Research, Bologna University, 40138 Bologna, Italy.
Marta OttoneGiovanni Brandi, Maria Abbondanza Pantaleo, Guido Biasco, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital and "G. Prodi" Interdepartmental Center for Cancer Research, Bologna University, 40138 Bologna, Italy.
Filippo Gustavo Dall'OlioGiovanni Brandi, Maria Abbondanza Pantaleo, Guido Biasco, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital and "G. Prodi" Interdepartmental Center for Cancer Research, Bologna University, 40138 Bologna, Italy.
Maria Aurelia BarberaGiovanni Brandi, Maria Abbondanza Pantaleo, Guido Biasco, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital and "G. Prodi" Interdepartmental Center for Cancer Research, Bologna University, 40138 Bologna, Italy.
Maria Abbondanza PantaleoGiovanni Brandi, Maria Abbondanza Pantaleo, Guido Biasco, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital and "G. Prodi" Interdepartmental Center for Cancer Research, Bologna University, 40138 Bologna, Italy.
Guido BiascoGiovanni Brandi, Maria Abbondanza Pantaleo, Guido Biasco, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital and "G. Prodi" Interdepartmental Center for Cancer Research, Bologna University, 40138 Bologna, Italy.
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical resection is the only option of cure for patients with metastatic colorectal cancer (CRC). However, the risk of recurrence within 18 mo after metastasectomy is around 75% and the liver is the most frequent site of relapse. The current international guidelines recommend an adjuvant therapy after surgical resection of CRC metastases despite the lower level of evidence (based on the quality of studies in this setting). However, there is still no standard treatment and the effective role of an adjuvant therapy remains controversial. The aim of this review is to report the state-of-art of systemic chemotherapy and regional chemotherapy with hepatic arterial infusion in the management of patients after resection of metastases from CRC, with a literature review and meta-analysis of the relevant randomized controlled trials.

Indexed as

HepatectomyAntineoplastic AgentsChemotherapy, AdjuvantColorectal NeoplasmsHepatic ArteryHumansInfusions, Intra-ArterialLiver NeoplasmsMetastasectomyRisk FactorsTreatment OutcomeAntineoplastic AgentsAdjuvant chemotherapyAdjuvant hepatic artery infusionColorectal cancerLiver metastasesMetastasectomy

Identifiers

PMID26811604
PMCPMC4716056
OpenAlexW2341588429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.